Human Epididymis Protein 4 (HE4)
Human epididymis protein 4 (HE4) is a protease inhibitor involved in sperm maturation usually found in the epithelium of the distal epididymis. HE4 is coded by the WFDC2 gene that is located on chromosome 20q12-13.1. In addition to epididymis, HE4 has been reported to be expressed in a number of normal tissues, including epithelia of respiratory and reproductive tissues. Elevated levels were found in tumors and neoplastic tissues, including ovarian, lung, colon, and breast cancer. HE4 is overexpressed in ovarian neoplastic tissue and it is elevated in the serum of patients with cancer of the ovary. Recent studies have demonstrated high sensitivity of HE4 compared with CA125, especially in the early stages of the disease. HE4 may have more potential than cancer antigen 125 (CA-125) in discriminating benign from cancerous ovarian masses, and has the strongest correlation with endometrial cancer of all markers tested to date. HE4 may ultimately be useful for detecting ovarian and endometrial cancer at an early stage in patients at high risk. Although sensitive, its sensitivity is increased if used in combination with CA-125 testing. HE4 is most useful as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for HE4 should be used in conjunction with other clinical methods for monitoring ovarian cancer.
- Monitoring recurrence/progressive disease in patients with epithelial ovarian cancer
- Management of ovarian cancer and therapy treatment
- As an aid in differential diagnosis of ovarian tumors from ovarian endometriotic cysts
Increased in:
- Ovarian cancer
- Endometrial cancer
- Lung cancer
- Colon cancer
- Breast cancer
0-150 pmol/L
Immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Clin Chem Lab Med. 2011 Sep 16. [PMID: 21923475]
- Expert Rev Mol Diagn. 2009 Sep;9(6):555-66. [PMID: 19732003]
- Tumour Biol. 2010 Apr;31(2):113-9. [PMID: 20358424]
- Gynecol Oncol. 2008; 110(2):196-201. [PMID: 18495222]
- Oncogene. 2002; 21(17):2768-73. [PMID: 11965550]
- Mod Pathol. 2006; 19(6):847-53. [PMID: 16607372]